Opinion|Videos|July 29, 2024
Managing Pain in Patients with Hidradenitis Suppurativa
Author(s)Vivian Shi, MD, FAAD
A dermatologist provides clinical insights on managing pain in patients with hidradenitis suppurativa.
Advertisement
Episodes in this series
Video content above is prompted by the following question:
- Pain management is an important goal of HS therapy. What is your approach to helping patients with this facet of the disease?
Advertisement
Related to this article
Remibrutinib (Rhapsido; Novartis) is the only treatment with approved uses in both chronic spontaneous urticaria and symptomatic dermographism.
Advertisement
Advertisement
Trending on AJMC
1
MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD
2
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
3
Multi-Hit TP53 Linked to Shorter Survival in Chronic-Phase MPN Cohorts
4
Navigating GLP-1 Access & Prior Authorizations: Amanda Velazquez, MD
5